Rang	Name	Position
1	Dr. Henry H. Ji Ph.D.	CEO, President & Executive Chairman
2	Mr. Stephen Ma	Senior VP, CFO, COO, Corporate Secretary & Director
3	Dr. Suketu D. Desai Ph.D.	Interim Chief Technical Officer & Senior VP
4	Ms. Gigi DeGuzman	VP & Chief People Officer
5	Mr. Suresh K. Khemani	Senior VP, Chief Commercial Officer & GM of Scilex Pharma
6	Dr. Dmitri V. Lissin M.D.	Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Armistice Capital, LLC	4,23%	1,57 Mio. USD
2	Vanguard Capital Management, LLC	3,75%	1,39 Mio. USD
3	BlackRock Inc	1,46%	0,54 Mio. USD
4	Vanguard Fiduciary Trust Co	0,56%	0,21 Mio. USD
5	Renaissance Technologies Corp	0,52%	0,20 Mio. USD
6	State Street Corp	0,50%	0,19 Mio. USD
7	XTX Topco Ltd	0,32%	0,12 Mio. USD
8	Northern Trust Corp	0,21%	0,08 Mio. USD
9	Morgan Stanley - Brokerage Accounts	0,17%	0,06 Mio. USD
10	Citigroup Inc	0,13%	0,05 Mio. USD
11	UBS Group AG	0,09%	0,03 Mio. USD
12	Vanguard Global Advisers, LLC	0,04%	0,02 Mio. USD
13	Creative Financial Designs Inc	0,03%	0,01 Mio. USD
14	Royal Bank of Canada	0,02%	0,01 Mio. USD
15	MetLife Investment Management, LLC	0,02%	0,01 Mio. USD
16	Deutsche Bank AG	0,01%	0,00 Mio. USD
17	Versant Capital Management Inc	0,01%	0,00 Mio. USD
18	JONES FINANCIAL COMPANIES LLLP	0,01%	0,00 Mio. USD
19	IFP Advisors, LLC	0,01%	0,00 Mio. USD
20	Mcf Advisors, LLC	0,01%	0,00 Mio. USD